By Josh White
Date: Tuesday 02 Jan 2024
LONDON (ShareCast) - (Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.
The AIM-traded firm said that as a result, investors would be issued 3,093,915 warrants, representing 40% of the drawdown's value divided by the reference price of 7.7572p.
It said the warrants would have an exercise price of 140% of the reference price, equating to 10.86p.
At 1336 GMT, shares in Genedrive were down 0.92% at 8.05p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
| Currency | UK Pounds |
| Share Price | 0.98p |
| Change Today | -0.069p |
| % Change | -6.61 % |
| 52 Week High | 2.50p |
| 52 Week Low | 0.23p |
| Volume | 31,876,736 |
| Shares Issued | 1,029.60m |
| Market Cap | £10.04m |
| RiskGrade | 747 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:14 | 149,554 @ 0.97p |
| 15:11 | 96,671 @ 0.99p |
| 14:59 | 16,746 @ 0.97p |
| 14:41 | 217,532 @ 0.97p |
| 14:25 | 936,720 @ 0.99p |
You are here: research